Ascendis Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.About ASND
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs.
CEOJan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees—
Employees—
HeadquartersHellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded2006
Founded2006
Employees—
Employees—
ASND Key Statistics
Market cap12.47B
Market cap12.47B
Price-Earnings ratio-41.45
Price-Earnings ratio-41.45
Dividend yield—
Dividend yield—
Average volume427.97K
Average volume427.97K
High today$208.39
High today$208.39
Low today$203.02
Low today$203.02
Open price$205.91
Open price$205.91
Volume289.40K
Volume289.40K
52 Week high$216.45
52 Week high$216.45
52 Week low$118.03
52 Week low$118.03
ASND News
Simply Wall St 1d
Assessing Ascendis Pharma (NasdaqGS:ASND) Valuation Following Expanded SKYTROFA Launch for Adult Growth Hormone DeficiencyAscendis Pharma (NasdaqGS:ASND) just announced that its SKYTROFA (TransCon hGH) is now broadly available in the United States, with expanded dosing options for...
Simply Wall St 4d
Did a Fatal Adverse Event Just Shift Ascendis Pharma's Yorvipath Investment Narrative?In the past week, an FDA adverse event report disclosed the death of a patient who had been treated with Ascendis Pharma’s hypoparathyroidism drug, Yorvipath, i...
Analyst ratings
100%
of 16 ratingsBuy
100%
Hold
0%
Sell
0%